According to a new report issued by Multnomah County Health Department, “Skin Cancer,” Oregon has one of the highest incidence rates in the U.S. of melanoma, the most serious type of skin cancer, along with Washington, Idaho, Utah, New Hampshire and Vermont.
Ads by Google
There is new hope for the treatment of chemotherapy-resistant malignant melanoma. Novel assay finds that widely prescribed anti-parasite drug targets cancer-causing protein.
Researchers at the NYU Cancer Institute and the Ronald O. Perelman Department of Dermatology have identified mebendazole, a drug used globally to treat parasitic infections, as a novel investigational agent for the treatment of chemotherapy-resistant malignant melanoma.
Melanoma cases of skin cancer increased by 50% in younger women, urging the need of more educational campaigns for younger people to help them understand how dangerous skin cancer is and what to do to protect themselves from the disease.
A team of researchers from National Cancer Institute examined data from government cancer statistics for the period between 1973 and 2004. Data from about 20000 skin cancer aged from 15 to 39 was examined in the study.
Recent research by the National Cancer Institute says that more women are being diagnosed with the most dangerous form of skin cancer melanoma. Too much sun exposure and lack of safe sunscreens contribute extensively in the sharp increase of Melanoma. While everyone is recommended to have reasonable amount of sun exposure (here you need to consult your doctor because sun exposure is needed for Vitamin D as well) it's important that you share this news with family and friends about being cautious from the risk of melanoma.
With a skin cancer rate among the 10 highest in the nation, Utah health officials are urging residents to take steps to keep their skin safe. Utah Department of Health (UDOH) data show that the rate of melanoma--the deadliest form of skin cancer--is increasing. In 2005, 554 Utahns were diagnosed with melanoma, up from 494 in 2004. Every year, melanoma kills an average of 63 Utah residents.
The good news is that skin cancer is preventable when sun protection measures are used consistently. UDOH and the Utah Cancer Action Network (UCAN) recommend:
Patient's own infection-fighting T cells put late-stage melanoma into long-term remission - without chemotherapy or radiation. Case is first to show safety and effectiveness of using cloned cells alone to kill tumors.
Disabling a protein frequently found in melanoma tumors may make the cancer more vulnerable to chemotherapy.
Results from an adjuvant trial in high-risk melanoma patients demonstrated that a majority of patients treated with Leukine (sargramostim) achieved disease-free and/or overall survival. These findings, which indicate Leukine's potential in this cancer setting, were released at the 44th annual meeting of the American Society of Clinical Oncology (ASCO).
Results from the Phase II study (ASCO abstract #20027) show that 60 percent of the 45 high-risk patients enrolled in the trial experienced disease-free survival and 64 percent of patients achieved overall survival at 21 months.
In this study, Genasense was used to potentially enhance the clinical activity of temozolomide, the most commonly used anticancer drug for melanoma, combined with Abraxane.
Scientists are urging everyone to take safety measures against sun rays during this summer and to protect themselves from skin cancer.